Symbols / OACC Stock $10.62 +0.00% Oaktree Acquisition Corp. III Life Sciences
OACC (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Ratings
- Fort Baker Capital (OACC) reports 5.1% ownership of Oaktree III - Stock Titan Fri, 15 May 2026 18
- Goldman Sachs Group reports 1,228,500 OACC shares (6.2%) — OACC - Stock Titan Mon, 11 May 2026 19
- Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Short Interest Down 45.5% in April - MarketBeat Mon, 27 Apr 2026 07
- Oaktree Acquisition Corp. III Life Sciences Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com Wed, 13 May 2026 20
- Oaktree Acquisition III Life Sciences (OACC) posts Q1 2026 interest income and flags going concern risk - Stock Titan Wed, 13 May 2026 20
- What is the future of Oaktree (OACC) Stock | Price at $10.65, Up 0.57% - Price Momentum - UBND thành phố Hải Phòng Wed, 08 Apr 2026 07
- symbol__ Stock Quote Price and Forecast - CNN Wed, 23 Oct 2024 23
- What is the future of Oaktree (OACC) Stock | Price at $10.65, Up 0.57% - Community Breakout Alerts - newser.com Wed, 08 Apr 2026 07
- OACC (Oaktree) highlights ongoing life sciences de-SPAC target evaluation efforts in latest quarterly earnings update. - newser.com Mon, 27 Apr 2026 07
- What is the future of Oaktree (OACC) Stock | Price at $10.65, Up 0.57% - Stock Picks - newser.com Wed, 08 Apr 2026 07
- OACC (Oaktree) highlights ongoing life sciences de-SPAC target evaluation efforts in latest quarterly earnings update. - Debt Refinancing - newser.com Mon, 27 Apr 2026 07
- What is the future of Oaktree (OACC) Stock | Price at $10.65, Up 0.57% - Safe Entry Stocks - newser.com Wed, 08 Apr 2026 07
- OACC (Oaktree) highlights ongoing life sciences de-SPAC target evaluation efforts in latest quarterly earnings update. - Community Risk Signals - newser.com Mon, 27 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 |
|---|---|---|
| Total Revenue |
|
0.00
|
| Operating Revenue |
|
0.00
|
| Operating Expense |
|
1.20
|
| Selling General And Administration |
|
1.20
|
| General And Administrative Expense |
|
1.20
|
| Other Gand A |
|
1.20
|
| Total Expenses |
|
1.20
|
| Operating Income |
|
-1.20
|
| Total Operating Income As Reported |
|
-1.20
|
| EBITDA |
|
-1.20
|
| Normalized EBITDA |
|
-1.20
|
| EBIT |
|
-1.20
|
| Net Income |
|
7.29
|
| Pretax Income |
|
7.29
|
| Net Non Operating Interest Income Expense |
|
8.48
|
| Net Interest Income |
|
8.48
|
| Interest Income Non Operating |
|
8.48
|
| Interest Income |
|
8.48
|
| Tax Rate For Calcs |
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
7.29
|
| Net Income From Continuing Operation Net Minority Interest |
|
7.29
|
| Net Income From Continuing And Discontinued Operation |
|
7.29
|
| Net Income Continuous Operations |
|
7.29
|
| Normalized Income |
|
7.29
|
| Net Income Common Stockholders |
|
7.29
|
| Diluted NI Availto Com Stockholders |
|
7.29
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Total Assets |
|
203.11
+4.03%
|
195.25
|
| Current Assets |
|
1.55
-0.65%
|
1.56
|
| Cash Cash Equivalents And Short Term Investments |
|
1.43
+5.74%
|
1.36
|
| Cash And Cash Equivalents |
|
1.43
+5.74%
|
1.36
|
| Cash Financial |
|
1.43
+5.74%
|
1.36
|
| Prepaid Assets |
|
0.11
-43.72%
|
0.20
|
| Total Non Current Assets |
|
201.56
+4.06%
|
193.69
|
| Non Current Prepaid Assets |
|
0.00
-100.00%
|
0.11
|
| Other Non Current Assets |
|
201.56
+4.12%
|
193.58
|
| Total Liabilities Net Minority Interest |
|
8.32
+7.39%
|
7.75
|
| Current Liabilities |
|
1.30
+78.69%
|
0.73
|
| Payables And Accrued Expenses |
|
1.29
+79.99%
|
0.72
|
| Payables |
|
1.29
+140.48%
|
0.54
|
| Accounts Payable |
|
0.50
-6.26%
|
0.54
|
| Current Accrued Expenses |
|
0.00
-100.00%
|
0.18
|
| Current Debt And Capital Lease Obligation |
|
0.01
+0.00%
|
0.01
|
| Current Debt |
|
0.01
+0.00%
|
0.01
|
| Other Current Borrowings |
|
0.01
+0.00%
|
0.01
|
| Total Non Current Liabilities Net Minority Interest |
|
7.02
+0.00%
|
7.02
|
| Tradeand Other Payables Non Current |
|
6.72
+0.00%
|
6.72
|
| Non Current Deferred Liabilities |
|
0.30
+0.00%
|
0.30
|
| Stockholders Equity |
|
194.79
+3.89%
|
187.50
|
| Common Stock Equity |
|
194.79
+3.89%
|
187.50
|
| Capital Stock |
|
201.56
+4.12%
|
193.58
|
| Common Stock |
|
201.56
+4.12%
|
193.58
|
| Preferred Stock |
|
0.00
|
0.00
|
| Share Issued |
|
24.58
+0.00%
|
24.58
|
| Ordinary Shares Number |
|
24.58
+0.00%
|
24.58
|
| Additional Paid In Capital |
|
0.00
|
0.00
|
| Retained Earnings |
|
-6.77
-11.45%
|
-6.08
|
| Total Equity Gross Minority Interest |
|
194.79
+3.89%
|
187.50
|
| Total Capitalization |
|
194.79
+3.89%
|
187.50
|
| Working Capital |
|
0.25
-70.09%
|
0.83
|
| Invested Capital |
|
194.81
+3.89%
|
187.52
|
| Total Debt |
|
0.01
+0.00%
|
0.01
|
| Net Tangible Assets |
|
194.79
+3.89%
|
187.50
|
| Tangible Book Value |
|
194.79
+3.89%
|
187.50
|
| Dueto Related Parties Current |
|
0.79
|
0.00
|
| Line Item | Trend | 2025-12-31 |
|---|---|---|
| Operating Cash Flow |
|
-0.42
|
| Cash Flow From Continuing Operating Activities |
|
-0.42
|
| Net Income From Continuing Operations |
|
7.29
|
| Other Non Cash Items |
|
-8.48
|
| Change In Working Capital |
|
0.77
|
| Change In Prepaid Assets |
|
0.20
|
| Change In Payables And Accrued Expense |
|
0.57
|
| Change In Accrued Expense |
|
-0.18
|
| Change In Payable |
|
0.75
|
| Change In Account Payable |
|
-0.03
|
| Investing Cash Flow |
|
0.50
|
| Cash Flow From Continuing Investing Activities |
|
0.50
|
| Net Other Investing Changes |
|
0.50
|
| Financing Cash Flow |
|
0.00
|
| Cash Flow From Continuing Financing Activities |
|
0.00
|
| Net Issuance Payments Of Debt |
|
0.00
|
| Repayment Of Debt |
|
0.00
|
| Short Term Debt Payments |
|
0.00
|
| Net Short Term Debt Issuance |
|
0.00
|
| Net Common Stock Issuance |
|
0.00
|
| Changes In Cash |
|
0.08
|
| Beginning Cash Position |
|
1.36
|
| End Cash Position |
|
1.43
|
| Free Cash Flow |
|
-0.42
|
| Common Stock Issuance |
|
0.00
|
| Issuance Of Capital Stock |
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|